Stock Events

Stock Events

Spyre Therapeutics (3920.STU) Q1 2026 Earnings

19FebConfirmed

Q1 2026

-0.6

-0.6

-0.6

-0.59

Details

Expected EPS

-0.6023413953000001

Actual EPS

-0.59451

Surprise EPS

0.01

Surprise Percent

+1.3%

Description

Spyre Therapeutics (3920.STU) has reported earnings of -0.59451 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.